Clinical Trial Update: Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for IDX21459 assessing single and multiple doses in healthy and Hepatitis C-infected subjects; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• IDX21459

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 1 | Status: TERMINATED